"Global Peptide Therapeutics Market 2016-2020" Published

Peptides are organic compounds that are composed of amino acids linked chemically by peptide bonds. They are the most potent biologically active substances found in nature and are used to trigger, control, and maintain an individual's physiological processes. However, using peptides as therapeutic agents was always difficult as they are quite instable and cannot pass through cellular membranes. They also require a specific technology to tackle extensive and challenging steps in their synthesis. Over 80 peptides are marketed by companies that explore the probabilities of designing and engineering peptides that can overcome their natural limits. They can be introduced as a treatment for chronic indications.

Technavio's analysts forecast the global peptide therapeutics market to grow at a CAGR of 7.92% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global peptide therapeutics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of prescription and generic drugs used to treat diseases.

Full Report Details at
- http://www.fastmr.com/prod/1131049_global_peptide_therapeutics.aspx?afid=302

The market is divided into the following segments based on geography:

* Americas
* APAC
* EMEA

Technavio's report, Global Peptide Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* Eli Lilly
* Novo Nordisk
* Sanofi
* Takeda Pharmaceutical
* Teva Pharmaceuticals

Other prominent vendors

* AbbVie
* Advanced Accelerator Applications
* Akashi Therapeutics
* Amgen
* Anthera Pharmaceuticals
* AstraZeneca
* Bachem
* Bristol-Myers Squibb
* Cardiorentis
* Corden Pharma International
* Debiopharm
* Derma Sciences
* GlaxoSmithKline
* Hanmi Pharmaceutical
* Insmed
* Ipsen
* Johnson & Johnson
* Lonza
* Mallinckrodt
* MolMed
* Merck
* Novartis
* Nymox Pharmaceutical
* Par Pharmaceuticals
* PeptiDream
* Polypeptide Group
* Radius Health
* Repligen
* Roche
* SciClone
* Shire
* The Medicines Company
* Transition Therapeutics
* X-Gen Pharmaceuticals
* Zealand Pharma
* Zydus Cadila

Market driver

* Increase in patient population
* For a full, detailed list, view our report

Market challenge

* High cost of therapy
* For a full, detailed list, view our report

Market trend

* Shifting focus toward untapped markets
* For a full, detailed list, view our report

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Strong Pipeline and Expanding Treatment Population to Encourage Robust Growth
- Global Biologic Therapeutics Market 2015-2019
- Glomerulonephritis Global Clinical Trials Review, H2, 2015
- Cancer Pain Global Clinical Trials Review, H1, 2015
- Glaucoma Global Clinical Trials Review, H1, 2015